Cargando…

Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()

Infection with human papilloma virus (HPV) is related to a great number of cutaneous and mucosal manifestations. The spectrum of HPV ranges from inapparent infections, through various clinical benign presentations including cutaneous and mucosal disease, to malignant and premalignant conditions. New...

Descripción completa

Detalles Bibliográficos
Autores principales: Magalhães, Geraldo Magela, Vieira, Érica Cristina, Garcia, Lucas Campos, De Carvalho-Leite, Maria de Lourdes Ribeiro, Guedes, Antônio Carlos Martins, Araújo, Marcelo Grossi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838122/
https://www.ncbi.nlm.nih.gov/pubmed/33341319
http://dx.doi.org/10.1016/j.abd.2020.11.003
_version_ 1783643102212259840
author Magalhães, Geraldo Magela
Vieira, Érica Cristina
Garcia, Lucas Campos
De Carvalho-Leite, Maria de Lourdes Ribeiro
Guedes, Antônio Carlos Martins
Araújo, Marcelo Grossi
author_facet Magalhães, Geraldo Magela
Vieira, Érica Cristina
Garcia, Lucas Campos
De Carvalho-Leite, Maria de Lourdes Ribeiro
Guedes, Antônio Carlos Martins
Araújo, Marcelo Grossi
author_sort Magalhães, Geraldo Magela
collection PubMed
description Infection with human papilloma virus (HPV) is related to a great number of cutaneous and mucosal manifestations. The spectrum of HPV ranges from inapparent infections, through various clinical benign presentations including cutaneous and mucosal disease, to malignant and premalignant conditions. New HPV types are currently described in the literature; many of them are characterized as high-risk types due to their oncogenic potential. Knowledge regarding their epidemiology and pathogenesis is important to understand not only infection and disease processes, but also to formulate the clinical and laboratory basis for diagnosis, therapeutics, and prophylactic measures. This non-systematic review aims to discuss and to update those aspects, with an emphasis on relevant topics for dermatologists. HPV infection and related diseases in the Brazilian scenario are highlighted, including common dermatologic conditions seen at clinics as well as the condition of a public health problem as a sexually transmitted infection. The oncogenicity of the virus and the variety of clinical outcomes – especially in the immunocompromised individuals – are addressed.
format Online
Article
Text
id pubmed-7838122
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Sociedade Brasileira de Dermatologia
record_format MEDLINE/PubMed
spelling pubmed-78381222021-02-01 Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()() Magalhães, Geraldo Magela Vieira, Érica Cristina Garcia, Lucas Campos De Carvalho-Leite, Maria de Lourdes Ribeiro Guedes, Antônio Carlos Martins Araújo, Marcelo Grossi An Bras Dermatol Continuing Medical Education Infection with human papilloma virus (HPV) is related to a great number of cutaneous and mucosal manifestations. The spectrum of HPV ranges from inapparent infections, through various clinical benign presentations including cutaneous and mucosal disease, to malignant and premalignant conditions. New HPV types are currently described in the literature; many of them are characterized as high-risk types due to their oncogenic potential. Knowledge regarding their epidemiology and pathogenesis is important to understand not only infection and disease processes, but also to formulate the clinical and laboratory basis for diagnosis, therapeutics, and prophylactic measures. This non-systematic review aims to discuss and to update those aspects, with an emphasis on relevant topics for dermatologists. HPV infection and related diseases in the Brazilian scenario are highlighted, including common dermatologic conditions seen at clinics as well as the condition of a public health problem as a sexually transmitted infection. The oncogenicity of the virus and the variety of clinical outcomes – especially in the immunocompromised individuals – are addressed. Sociedade Brasileira de Dermatologia 2021 2020-12-10 /pmc/articles/PMC7838122/ /pubmed/33341319 http://dx.doi.org/10.1016/j.abd.2020.11.003 Text en © 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier España, S.L.U. http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Continuing Medical Education
Magalhães, Geraldo Magela
Vieira, Érica Cristina
Garcia, Lucas Campos
De Carvalho-Leite, Maria de Lourdes Ribeiro
Guedes, Antônio Carlos Martins
Araújo, Marcelo Grossi
Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title_full Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title_fullStr Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title_full_unstemmed Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title_short Update on human papilloma virus - part I: epidemiology, pathogenesis, and clinical spectrum()()
title_sort update on human papilloma virus - part i: epidemiology, pathogenesis, and clinical spectrum()()
topic Continuing Medical Education
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838122/
https://www.ncbi.nlm.nih.gov/pubmed/33341319
http://dx.doi.org/10.1016/j.abd.2020.11.003
work_keys_str_mv AT magalhaesgeraldomagela updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum
AT vieiraericacristina updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum
AT garcialucascampos updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum
AT decarvalholeitemariadelourdesribeiro updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum
AT guedesantoniocarlosmartins updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum
AT araujomarcelogrossi updateonhumanpapillomaviruspartiepidemiologypathogenesisandclinicalspectrum